CLINICAL DIAGNOSTIC REAGENTS MEDICAL

Brand Owner (click to sort) Address Description
GENYX MTPCR Pty Ltd 290-292 Coward Street Mascot, NSW 2020 Australia Clinical diagnostic reagents for medical and veterinary use, including in vitro diagnostic reagents;
GUIDEPX Qualisure Diagnostics Inc. 363 Varsity Close NW Calgary AB T3B2Y9 Canada Clinical diagnostic reagents for medical use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; pharmaceutical preparations for in vivo diagnostic or therapeutic use, namely, i-vivo diagnostic agent used for detection and monitoring of tumors; drug test kits containing medical diagnostic reagents and assays for testing of body fluids;GUIDE PX;Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis;Testing apparatus for medical purposes, namely, for testing blood, tissue biopsies, tumors, cells, cancer cells, DNA, RNA, biomarkers; apparatus for use in medical analysis, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; diagnostic apparatus for medical purposes, namely, detecting tumors; medical diagnostic apparatus for testing blood, tissue biopsies, tumors, cells, cancer cells, DNA, RNA, incorporating recorded software using a machine learning algorithm to examine genomic information and identify biomarkers;
PURYX MTPCR Pty Ltd 290-292 Coward Street Mascot, NSW 2020 Australia Clinical diagnostic reagents for medical and veterinary use, including in vitro diagnostic reagents;
VERESCA 3N Diagnostics Ltd 1 Murray Street Belfast Belfast BT1 6DN United Kingdom Clinical diagnostic reagents for medical purposes; diagnostic agents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical use; in vitro diagnostic preparations for medical use; diagnostic testing materials for medical use, namely, materials for testing antibodies; reagents for use in diagnostic testing for medical purposes;The wording VERESCA has no meaning in a foreign language.;Providing breast cancer screening services; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; medical laboratory services for the analysis of samples taken from patients; medical services in the field of oncology; medical testing services relating to the diagnosis and treatment of disease; pathology services for the diagnosis and treatment of diseases; performing diagnosis of diseases; providing prostate cancer screening services; providing cancer screening services; providing information relating to medical services; providing medical information; providing medical information in the healthcare sector; analysis of human tissues for medical treatment; chemotherapy services; medical analysis for the diagnosis and treatment of persons; medical analysis services relating to the treatment of persons provided by a medical laboratory, namely, medical diagnostic testing, monitoring and reporting services in the field of oncology; medical care and analysis services relating to patient treatment; medical counselling; medical diagnostic services in the nature of breast cancer screening; medical analysis services relating to the treatment of patients; medical consultations; medical testing for diagnostic or treatment purposes;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A method and apparatus are provided for adjusting a dynamic range of a digital medical image for a medical imaging system. The digital medical image contains a clinical region and a non-clinical region. The method and apparatus identify the non-clinical region of the digital medical image and mask the non-clinical region therefrom to form a clinical image. The clinical image is then used to calculate a desired dynamic range for the medical imaging system. The dynamic range of the medical imaging system is adjusted accordingly. According to one embodiment, the non-clinical region is identified by dividing the digital medical image into bands of a predetermined width, generating profiles for each band and differentiating the profiles to obtain a differentiated profile of each band of a digital medical image. The differentiated profile is than analyzed to identify peaks that exceed predetermined thresholds, wherein the regions of the differentiated profile proximate the peaks exceeding the threshold correspond to non-clinical regions. Once the non-clinical regions are identified, they are masked or removed. Next, a desired image characteristic, such as maximum and minimum gray scale values, are determined for the clinical region and a desired dynamic range for the image is obtained based on the image characteristics of the clinical region. In an alternative embodiment, a histogram is used to identify the non-clinical regions which are subsequently masked from the digital medical image.